AzTrials
AzTrials

Preload-responsivenessNCT05538637

Is Mitral Velocity Time-integral a Marker of Preload-responsiveness in Patients With Acute Circulatory Failure?

An observational study of Preload-responsiveness, run by Avicenna Military Hospital at 1 site in Morocco.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this is to assess the reliability of the variability of the mitral velocity time-integral with passive leg raising to predict the fluid responsiveness in patients with acute circulatory failure in intensive care. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Preload-responsiveness
What is being tested?
Echocardiography
How many people
50 participants
Where
1 siteMorocco
Study dates
6 Nov 2022to 6 Nov 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients with acute circulatory failure, with or without arterial hypotension. Acute circulatory failure is defined by the presence of signs of tissue hypoperfusion : prolonged capillary refil time (>5 seconds), mottling, acrocyanosis, oliguria (<0.5 mL/kg/h for more than an hour), altered mental status, lactate>2 mmol/l or metabolic acidosis (pH<7.35, base excess >-5). Arterial hypotension is defined by systolic blood pressure (SBP) < 90mmHg, mean arterial pressure (MAP) < 65 mmHg or a drop in SBP ≥ 40 mmHg. Shock is defined by the association of an acute circulatory failure and arterial hypotension.

Who may be able to join

None listed.

Who cannot join

  • Recent surgery (<5 days)
  • Suspected or confirmed intra-abdominal hypertension.
  • Intracranial hypertension.
  • Severe mitral valve disease: Severe mitral insufficiency or severe mitral stenosis
  • Acute cor pulmonale
  • Atrial fibrillation
  • Low echogenicity

Trial locations and contacts

1 site in 1 country.

Morocco1 site
  • Avicenna Military Hospital

    Marrakesh, Marrakesh Tensift El Haouz, 40000

Other trials in Morocco

About this study

Official title: Reliability and Accuracy of Mitral Velocity Time-integral Variability With Passive Leg Raising as a Marker of Preload-responsiveness in Patients With Acute Circulatory Failure in the ICU.

The aim of this is to assess the reliability of the variability of the mitral velocity time-integral with passive leg raising to predict the fluid responsiveness in patients with acute circulatory failure in intensive care.

Read the detailed description

Adult patients with acute circulatory failure will be included in the study. An initial echocardiography is performed in patients placed in a semi-recumbent position. On the apical views (4 and 5-chamber views), the left ventricular outflow tract velocity time integral (LVOT-VTI) and mitral valve (MV-VTI) velocity time integral are measured (baseline values). Then a passive leg raise test is performed and the parameters (LVOT-VTI and MV-VTI) are measured again. Preload-responsiveness is defined by an increase in LVOT-VTI of at least 10%. In preload-responsive patients, a fluid loading with 500 ml of 0.9% saline administered over 15 minutes is performed. Immediately after fluid therapy, the same parameters are recorded during a third echocardiography. An increase of 10% or more of LVOT-VTI , compared with baseline, defines fluid responsiveness. Patients are monitored using the standard of care practices. Hemodynamic assessment includes repetitive echocardiographic examinations if needed. In patients with shock, invasive blood pressure is monitored with an arterial catheter.

Being tested
Echocardiography
Keywords
preload-responsiveness, acute circulatory failure, left ventricular outflow tract velocity time integral, mitral valve velocity time integral, echocardiography
Medical subject headings
Shock

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EchocardiographyDiagnostic test

    Also called Mitral velocity time-integral variability

    Mitral velocity time-integral variability measurement before and after passive leg raising.

    Mitral velocity time-integral variability measurement after fluid loading in preload-responsiveness patients.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Reliability and accuracy of the change in mitral valve velocity time-integral (cm) to discriminate preload-responsiveness

    Reliability and accuracy of the change in mitral valve velocity time-integral (cm) measured by echocardiography (before and after passive leg raising) to discriminate preload-responsive patients.

    Measured: through study completion, an average of 6 months

  2. Reliability and accuracy of the change in mitral valve velocity time-integral (cm) to discriminate fluid-responsiveness

    Reliability and accuracy of the change in mitral valve velocity time-integral (cm) measured by echocardiography (before and after fluid loading with 500 ml of saline) to discriminate fluid-responsive patients.

    Measured: through study completion, an average of 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Sep 2022
  2. Study start6 Nov 2022
  3. Primary completion6 Nov 2024
  4. Study completion6 Nov 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05538637
Sponsor's protocol ID
Mitral VTI ICU-AMH
Status last verified
Nov 2024
First submitted
6 Sep 2022
Last updated
7 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data that support the findings of this study will be available from the principal investigator upon reasonable request.

Publications

  • Aissaoui Y, Belhadj A, Eddakya W, Bencharfa B, Bouchama A, Didi M, Elbaraka H, Fassiki N, Myatt I, Qamouss Y, Leone M, Abouqal R. Early hemodynamic phenotyping in sepsis using transthoracic echocardiography: A proof-of-concept study in a north African ICU. J Crit Care. 2026 Aug;94:155504. doi: 10.1016/j.jcrc.2026.155504. Epub 2026 Feb 26.

    PubMed 41759300
  • Aissaoui Y, Jozwiak M, Bouchama A, Bennjakhoukh H, Bencharfa B, Didi M, Abouqal R, Belhadj A. Evaluation of the mitral velocity-time integral changes induced by a passive leg raising test as a marker of fluid responsiveness in critically ill patients. J Clin Monit Comput. 2025 Dec;39(6):1159-1168. doi: 10.1007/s10877-025-01320-z. Epub 2025 Jul 8.

    PubMed 40627255

Questions about this trial

What is this clinical trial studying?

An observational study of Preload-responsiveness, run by Avicenna Military Hospital at 1 site in Morocco.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Morocco. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Reliability and accuracy of the change in mitral valve velocity time-integral (cm) to discriminate preload-responsiveness (time frame: through study completion, an average of 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05538637, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in